| Literature DB >> 34939322 |
Astrid Wintering1, Stephen Smith2, Beng Fuh3, Arun Rangaswami1, Gary Dahl4, May Chien4, Tanja A Gruber4, Jinjun Dang4, Loretta S Li5, Alicia Lenzen5, Stephanie Savelli6, Christopher C Dvorak1,7, Anurag K Agrawal2,7, Elliot Stieglitz1,7.
Abstract
Therapy-related myeloid neoplasms (t-MN) are a distinct subgroup of myeloid malignancies with a poor prognosis that include cases of therapy-related myelodysplastic syndrome (t-MDS), therapy-related myeloproliferative neoplasms (t-MPN) and therapy-related acute myeloid leukemia (t-AML). Here, we report a series of patients with clinical features consistent with juvenile myelomonocytic leukemia (JMML), an overlap syndrome of MDS and myeloproliferative neoplasms that developed after treatment for another malignancy.Entities:
Keywords: AML; JMML; MDS; secondary; therapy related
Mesh:
Year: 2021 PMID: 34939322 PMCID: PMC8957526 DOI: 10.1002/pbc.29499
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167